The C−509T polymorphism (rs1800469) of the TGF-β1 promoter has been found to be related to an elevated plasma level of TGF-β1, an elevated level of total IgE and an increased risk of remodeling bronchi, as well as the development of asthma (26–31). The gene discussed is IGHE; the disease is asthma.